Professional
Added to YB: 2024-12-13
Pitch date: 2024-10-20
LFCR [neutral]
Lifecore Biomedical, Inc.
+47.82%
current return
Author Info
No bio for this author
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
Market Cap
$298.2M
Pitch Price
$5.27
Price Target
N/A
Dividend
N/A
EV/EBITDA
-128.16
P/E
-6.25
EV/Sales
3.62
Sector
Life Sciences Tools and Services
Category
turnaround
Arquitos Capital Management Portfolio Holding: Lifecore Biomedical, Inc.
LFCR trimmed position: Specialty pharma co. divested non-core biz, failed sale attempt due to restatement issues. New mgmt & board. $4.10/sh raise. Increased fill/finish capacity, demand from weight loss drugs, but long lead times for contracts. Long-term potential for sale, but near-term execution concerns. Exited for now.
Read full article (2 min)